ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 60 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $109,319 | +72779.3% | 14,733 | -7.5% | 0.00% | -100.0% |
| Q1 2023 | $150 | -6.2% | 15,923 | +5.6% | 0.00% | 0.0% |
| Q4 2022 | $160 | -99.8% | 15,081 | +5.2% | 0.00% | 0.0% |
| Q3 2022 | $105,000 | +72.1% | 14,331 | +11.3% | 0.00% | – |
| Q2 2022 | $61,000 | +1.7% | 12,881 | +8.4% | 0.00% | – |
| Q1 2022 | $60,000 | +20.0% | 11,881 | +41.8% | 0.00% | – |
| Q4 2021 | $50,000 | -32.4% | 8,381 | 0.0% | 0.00% | – |
| Q3 2021 | $74,000 | +37.0% | 8,381 | +21.8% | 0.00% | – |
| Q2 2021 | $54,000 | +3.8% | 6,881 | 0.0% | 0.00% | – |
| Q1 2021 | $52,000 | +79.3% | 6,881 | +82.0% | 0.00% | – |
| Q4 2020 | $29,000 | +45.0% | 3,780 | +79.7% | 0.00% | – |
| Q3 2020 | $20,000 | – | 2,103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 90,000 | $702,000 | 0.41% |
| Rubric Capital Management LP | 294,683 | $2,299,000 | 0.17% |
| Interchange Capital Partners, LLC | 24,420 | $190,000 | 0.10% |
| GOODWIN DANIEL L | 20,000 | $156,000 | 0.09% |
| Consonance Capital Management LP | 88,428 | $690,000 | 0.06% |
| DCM Advisors, LLC | 13,300 | $104,000 | 0.06% |
| Virtu Financial LLC | 27,524 | $215,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 68,899 | $537,000 | 0.01% |
| Lindbrook Capital, LLC | 1,000 | $8,000 | 0.00% |
| ExodusPoint Capital Management, LP | 11,900 | $93,000 | 0.00% |